| Dr Julian Fernando Naranjo, MD | |
|
7000 Sw 62nd Ave, Suite 535, South Miami, FL 33143-4716 | |
| (786) 268-4044 | |
| (855) 490-4044 |
| Full Name | Dr Julian Fernando Naranjo |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 36 Years |
| Location | 7000 Sw 62nd Ave, South Miami, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093700015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | ME71418 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marilu Home Health Care Inc | Doral, FL | Home health agency |
| South Miami Hospital | South miami, FL | Hospital |
| Doctors Hospital | Coral gables, FL | Hospital |
| Memorial Hospital Miramar | Miramar, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Synovation Medical Group Llc | 2860590098 | 4 |
News Archive
Kessler Foundation received a four-year $750,000 grant from the National Multiple Sclerosis Society to conduct a randomized controlled trial of speed of processing training to improve cognition in multiple sclerosis (MS).
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Physiological differences between men and women may contribute to differential tumor development and progression in colon cancer patients, a study led by researchers at the University of Southern California (USC) suggests.
Existing urban water systems are at the end of their design lifetimes. New, innovative solutions are needed, and these must combine technology and engineering with an understanding of social systems and institutions. The current issue of Environmental Engineering Science, the Official Journal of the Association of Environmental Engineering and Science Professors, focuses on Re-inventing Urban Water Systems.
Accumulating evidence suggests that connective tissue growth factor (CCN2) plays a central role in fibrotic conditions in many organ systems. Fibrosis is a scarring condition that is characterized by excessive collagen production that impedes normal cell function and can cause organ dysfunction and failure.
› Verified 4 days ago
| Entity Name | Synovation Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306942602 PECOS PAC ID: 2860590098 Enrollment ID: O20070612000007 |
News Archive
Kessler Foundation received a four-year $750,000 grant from the National Multiple Sclerosis Society to conduct a randomized controlled trial of speed of processing training to improve cognition in multiple sclerosis (MS).
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Physiological differences between men and women may contribute to differential tumor development and progression in colon cancer patients, a study led by researchers at the University of Southern California (USC) suggests.
Existing urban water systems are at the end of their design lifetimes. New, innovative solutions are needed, and these must combine technology and engineering with an understanding of social systems and institutions. The current issue of Environmental Engineering Science, the Official Journal of the Association of Environmental Engineering and Science Professors, focuses on Re-inventing Urban Water Systems.
Accumulating evidence suggests that connective tissue growth factor (CCN2) plays a central role in fibrotic conditions in many organ systems. Fibrosis is a scarring condition that is characterized by excessive collagen production that impedes normal cell function and can cause organ dysfunction and failure.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julian Fernando Naranjo, MD Po Box 223187, Hollywood, FL 33022-3187 Ph: (954) 457-0064 | Dr Julian Fernando Naranjo, MD 7000 Sw 62nd Ave, Suite 535, South Miami, FL 33143-4716 Ph: (786) 268-4044 |
News Archive
Kessler Foundation received a four-year $750,000 grant from the National Multiple Sclerosis Society to conduct a randomized controlled trial of speed of processing training to improve cognition in multiple sclerosis (MS).
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Physiological differences between men and women may contribute to differential tumor development and progression in colon cancer patients, a study led by researchers at the University of Southern California (USC) suggests.
Existing urban water systems are at the end of their design lifetimes. New, innovative solutions are needed, and these must combine technology and engineering with an understanding of social systems and institutions. The current issue of Environmental Engineering Science, the Official Journal of the Association of Environmental Engineering and Science Professors, focuses on Re-inventing Urban Water Systems.
Accumulating evidence suggests that connective tissue growth factor (CCN2) plays a central role in fibrotic conditions in many organ systems. Fibrosis is a scarring condition that is characterized by excessive collagen production that impedes normal cell function and can cause organ dysfunction and failure.
› Verified 4 days ago
Dr. Raul Vicente Chao, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6285 Sunset Dr, South Miami, FL 33143 Phone: 305-662-2925 Fax: 305-662-7840 | |
Guillermo Luis Pol,, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-242-4575 | |
Akshay Goyal, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6200 Sunset Dr Ste 120, South Miami, FL 33143 Phone: 786-596-3876 Fax: 786-533-9989 | |
Kylash Konanur, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7031 Sw 62nd Ave, South Miami, FL 33143 Phone: 305-284-7761 | |
Dr. John Robert Wall Iii, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7031 Sw 62nd Ave, South Miami, FL 33143 Phone: 305-284-7761 | |
Julio J Nunez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7031 Sw 62nd Ave, South Miami, FL 33143 Phone: 954-967-0107 Fax: 954-967-0109 |